Ukraine vs Israel, the US & Europe: Where to Deploy Defense Capital

The question usually arrives as a ranking — which defense market is best in 2026. It answers better as four distinct assets, because each one prices a different scarce thing. The United States prices access to programs of record. Europe prices a political commitment that has not yet fully converted into contracts. Israel prices an export machine that already works. Ukraine prices capability that has been validated against a peer adversary and has not yet been bid up.

Read the table below as direction rather than as a like-for-like league table. The figures sit on different measurement bases — national budgets, export receipts, production capacity, disclosed venture — and comparing a budget to a capacity estimate is only ever indicative. Every Ukrainian figure here is carried at the values on our source-of-record data page, which is where the sourcing and dating for the series lives.

Nothing in the world matches the American demand base. FY2026 national defense totals roughly $1.05 trillion — about $893 billion through normal appropriations plus reconciliation money — an increase of more than 17%. Private capital has followed at scale: PitchBook put defense-tech venture at a record $49.9 billion in 2025, up 83% on the prior year, with the number of firms actively investing in the sector up 41%. On the narrower military and national-security definition Crunchbase tracks, 2025 came in near $9.6 billion, and the first five months of 2026 alone passed $14.6 billion.

The consequence shows up in the price. Anduril raised a $5 billion Series H at a $30.5 billion valuation; Shield AI raised $2 billion; Saronic raised $1.75 billion. These are not seed entries into an emerging market. They are late-stage positions in companies whose valuations already assume they win the programs they are bidding for. What is scarce in the United States is allocation into the good rounds, and the terms on which it is offered reflect that.

For an allocator who needs liquidity, familiar governance and a deep comparable set, this is the right market and the price is the price of those things. It is also, straightforwardly, the market where the mispricing was arbitraged away first.

Europe has the most dramatic change in direction. At The Hague in June 2025, NATO members committed to 5% of GDP by 2035 — at least 3.5% for core defence requirements plus up to 1.5% for broader defence and security investment — with progress reviewed in 2029. In 2025 alone, European allies and Canada raised defence expenditure by over $90 billion in 2021 prices, close to $139 billion in nominal terms, a nearly 20% year-on-year increase. Alongside it, the EU's SAFE instrument put up to €150 billion of loans behind joint procurement as the first pillar of the ReArm Europe plan.

The venture layer has responded. European defence, security and resilience startups raised a record $8.7 billion in 2025, up 55% year on year and roughly four times the 2020 level, with late-stage funding tripling to $4.7 billion. The UK led at $2.9 billion and Germany followed at $2.1 billion; AI underpinned 44% of all funding, and rounds over $100 million accounted for slightly more than half of the year's volume. Helsing's €600 million Series D marked the company near $14 billion.

Two things temper it. The first is the clock: a spending pledge with a 2035 horizon converts into company revenue through procurement cycles measured in years, and the gap between a budget line and a signed contract is where European defense investments are actually underwritten. The second is liquidity — European DSR recorded roughly 20 M&A deals in 2025 and no public listing at all. Europe rewards an investor with a long horizon and a genuine tolerance for procurement timelines.

Israel is the clearest proof that combat validation converts into commercial outcomes. Defense exports hit a record $19.2 billion in 2025, close to 30% up on the prior year and the fifth consecutive annual record, according to the Israeli Ministry of Defense. Government-to-government agreements made up about $10 billion of that, more than half the total; Europe took 36% of exports and the Asia-Pacific 32%; 53% of agreements exceeded $100 million. Around 800 startups are filling procurement orders for the ministry directly.

That is the model every wartime defense ecosystem is measured against, and it is the reason the second number matters so much. Israeli defense-tech startups raised roughly $150 million in 2024, about $1 billion in 2025 — more than every prior year combined — and close to $3 billion in the first half of 2026, when defense and dual-use companies took almost 30% of the $8.4 billion invested across Israeli high tech. A sector can be repriced by a factor of twenty in two years, and this one was.

The practical reading for an allocator is uncomfortable and useful. The entry window that made the Israeli defense-tech story attractive closed between 2024 and 2026. An investor describing what they wish they had bought in Israel in 2024 — validated hardware, a state customer absorbing everything produced, prices set before the institutional money arrived — is describing the Ukrainian market as it stands today.

Ukraine's demand base is real and it is large. Production capacity reached roughly $35 billion in 2025 and is projected toward ~$55 billion in 2026 (KSE Institute), against about $1 billion in 2022. Only about a third of 2025 capacity was covered by domestic contracts, and Ukraine puts its 2026 defense funding gap near €19.6 billion. The capability is validated continuously against an adversary that iterates in weeks, which is a form of proof no test range in the other three markets can manufacture.

The capital side has not caught up. Disclosed private venture in 2025 was roughly $57.2 million across 28 deals (PitchBook), or about $105 million once angel cheques and grants are counted (Brave1). Average tickets run between $300k and $1M. Underneath that, the cost basis compounds the case: Ukraine builds an estimated 30–50% below Western Europe and qualified engineers cost roughly 3–5× less.

Set private capital against the demand it serves and the spread is the whole argument. In Israel, disclosed startup venture in 2025 ran near five percent of the value of the country's defense exports. In Europe, DSR venture was somewhere close to one and a half percent of what NATO Europe and Canada spent. In the United States, the narrow military and national-security bucket sat near one percent of national-defense spending. In Ukraine, disclosed private venture was under two-tenths of one percent of production capacity. The denominators measure different instruments, so the precise ratios are indicative — the order of magnitude between them is not.

Proof points exist on the exit side now, in small numbers. Swarmer became the first Ukrainian defense company to list on Nasdaq; UFORCE has been marked near $1 billion on roughly 450% growth in bookings; and in May 2026 the sector recorded its first realized venture exit, when TAF Industries took a majority of the Teslia platform and the early backer Resist.UA sold out entirely. How that value gets realized is mapped in the exit guide, and what it means for a return is worked through in the buy-side return case.

A price that far below three comparable markets is compensation for something specific. There are three items on the invoice, and each is underwritable before you commit.

• An active war. Physical risk sits on production sites and supply lines. Companies mitigate it with distributed or duplicable production, and investors mitigate it with political-risk cover — the US DFC has transacted about $848 million in Ukraine since 2022, though that is reconstruction-wide political-risk insurance rather than a defense-capital facility. The full risk picture is in whether it is safe to invest at all.
• Structuring work before the wire. Foreign capital enters through a cross-border holding with IP assigned to the company and a clean beneficial-ownership trail. In the United States that infrastructure is assumed; here it is a workstream with a timeline, and it is the single most common reason a deal slips.
• A thin exit record. One realized venture exit and one listing is a beginning. American and European buyers work against decades of comparable transactions, so a Ukrainian position is underwritten on a longer hold and a narrower set of precedents.

One thing that belongs in the strength column rather than the risk column is the team. Key engineering staff at Ukrainian defense companies hold critical-infrastructure reservation status, and Defence City residency carries a full mobilization exemption, so the engineering team you diligence is the team that ships the product. Price the three items above properly and the discount stops looking like a puzzle.

Because the four markets sell different things, the allocation question resolves into four clean conditions.

1. 1You need liquidity, familiar governance and a deep comparable set — take the United States and pay US prices for those attributes.
2. 2You are underwriting a decade of European rearmament and can wait for procurement to convert — take Europe, sized for a long horizon and a thin exit market.
3. 3You want an export machine that already runs, with government-to-government channels intact — take Israel, at the marks it now trades on.
4. 4You are buying validated capability at the earliest price still available anywhere — take Ukraine, with war risk, structuring and hold period explicitly underwritten.

In practice most institutional programs run core positions in the first three and a small, deliberately sized sleeve in the fourth. The Ukrainian allocation is where the asymmetry lives, which is exactly why it should be sized to survive being wrong. Diversify inside it as well — across product category, stage and single-site exposure — because at this stage of a market the return is a portfolio outcome.